Kokesova A et al. also demonstrated that urinary I-FABP in gastroschisis patients, which might be released by increased intra-abdominal pressure, oxidative stress, and an increase in apoptotic activity of enterocytes, can be a biomarker for intestinal mucosal disruption [25]. Here, FABP2 is linked to gastroschisis.